In summary, we demonstrate that the TruSeqTM RNA Exome next-generation sequencing workflow combined with FRICTION, an immune cell deconvolution algorithm, can predict the presence of CD4+ T cells, CD8+ T cells, and CD19+ B cells within tumor microenvironment in a quantitative manner and accurately determine the inflammation of the tumor microenvironment. Here, CD19 is linked to neoplasm.